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Edited by Vladimir SkulachevAbstract To examine the role of p66shc in endothelial dysfunc-
tion, we investigated the endothelium-dependent relaxation, pro-
tein expression and superoxide production in abdominal aortic
coarctation rats. Endothelium-dependent relaxation to acetyl-
choline was impaired only in the aortic segments above the aortic
coarctation (35.0±7.1% vs. 86.6 ± 6.0% for sham control at
1 lM Ach). The aortic segments exposed to increased blood
pressure showed a decreased phosphorylation of endothelial ni-
tric oxide synthase, an increased phosphorylation of p66shc,
and an increased superoxide production. Angiotensin II elicited
a signiﬁcantly increased phosphorylation of p66shc in the endo-
thelial cells. Taken together, these ﬁndings suggest that the in-
creased phosphorylation of p66shc is one of the important
mediators in the impaired endothelium-dependent relaxation of
aortic coarctation rats.
 2008 Federation of European Biochemical Societies.
Published by Elsevier B.V. All rights reserved.
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Superoxide1. Introduction
The vascular superoxide production has been shown to de-
crease the bioavailability of endothelial derived nitric oxide
(NO), thereby contributing to the impairment of endothe-
lium-dependent relaxation in the vascular system [1–3]. Indeed,
the enhanced production of reactive oxygen species (ROS) has
been recognized as a major determinant of endothelial dys-
function [4,5].
Shc is an adaptor protein containing a C-terminal src
homology collagen domain-2. In response to several growth
factors, Shc was tyrosin-phosphorylated and associated withAbbreviations: eNOS, endothelial nitric oxide synthase; Ach, acetyl-
choline; NO, nitric oxide; ROS, reactive oxygen species; Shc, src
homology and collagen; Mn SOD, manganese superoxide dismutase;
Cu/Zn SOD, copper/zinc superoxide dismutase; MS-1, mouse endo-
thelial cells
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doi:10.1016/j.febslet.2008.06.026Grb2 and SOS. This assembly of Shc/Grb2/SOS mediated
extracellular signals into intracellular signals. The mammalian
adaptor protein ShcA has three isoforms with relative molecu-
lar masses of 46, 52, and 66 kDa. p66shc possesses an N-termi-
nal collagen-homology domain that is not present in p46shc
and p52shc. p66shc was phosphorylated on serine 36 within
the N-terminal domain in response to oxidative stress. In its
ability to govern the ROS level, p66shc plays an important role
of oxidative stress responses and life span [6–9]. In fact,
p66shc(/) mice showed an increased life span [7] and exhib-
ited less atherosclerosis during a high-fat diet [10], suggesting
that p66shc is involved in aging and aging-associated disorder.
Recently, genetic deletion of p66shc has been found to pre-
vent the hyperglycemia-induced endothelial dysfunction and
oxidative stress [11]. RNAi-mediated down-regulation of
endogenous p66shc has led to the activation of phosphoryla-
tion of endothelial nitric oxide synthase (eNOS) at S1177
[12,13].
The abdominal aortic coarctation above the renal artery is
known to cause hypertension proximal to the level of constric-
tion as a consequence of reduced renal perfusion and subse-
quent activation of the renin–angiotensin system [14,15]. The
enhanced nitric oxide inactivation in thoracic aorta of aortic
coarctation induces the impairment of vascular function [16],
and the aortic coarctation-induced superoxide ðO2 Þ produc-
tion has been reported to increase by an upregulation of
NAD(P)H oxidation isoforms [17–19]. Angiotensin II in
hypertension is well known for its critical role in the induction
of endothelial dysfunction and vascular remodeling [20,21].
Angiotensin II stimulates the tyrosin phosphorylation of Shc
in the endothelial cells [22].
However, the role of p66shc adaptor protein in the change of
arterial pressure such as abdominal aortic coarctation has been
unknown. We hypothesized that the increased phosphoryla-
tion of p66shc may be linked with the impairment of endothe-
lium-dependent relaxation in hypertensive animals. Thus, we
investigated whether the alteration of p66shc is associated with
endothelial dysfunction in the abdominal aortic coarctation
models and in the cultured endothelial cells.2. Materials and methods
2.1. Cell cultures
Mouse endothelial cells (MS-1) were purchased from American
Type Culture Collection. Cells were grown in Dulbecco-modiﬁed Eagle
medium (DMEM) with 10% fetal bovine serum, 10 U/ml penicillin,
and 10 lg/ml streptomycin.blished by Elsevier B.V. All rights reserved.
Table 1
Hemodynamic changes of blood pressure and heart rate in the










Carotid 107 ± 6 78 ± 4 88 ± 4 274 ± 20
Femoral 110 ± 6 81 ± 8 91 ± 7
Coarctation
Carotid 148 ± 6a 95 ± 5a 113 ± 6a 293 ± 14
Femoral 49 ± 3b 45 ± 4b 47 ± 4b
Blood pressures were measured in the carotid artery and femoral artery
in the anesthetized sham-operated and aortic coarctation rats. Blood
pressures measured in carotid artery were signiﬁcantly elevated in the
coarctation rats (aP < 0.05 vs. carotid artery of sham-operated rats). In
contrast, blood pressures measured in femoral artery were signiﬁcantly
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Fig. 1. Endothelium-dependent relaxation by acetylcholine in the
abdominal aortic coarctation rats. Endothelium-dependent relaxation
in the aortic rings was evoked by the treatment of acetylcholine at the
range of 1 nM  10 lM. Relaxations are expressed as a relaxation
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Male Sprague–Dawley rats (5–6 weeks old and 200–250 g, n = 20)
were randomly assigned with abdominal aortic coarctation and
sham-operated control groups. In brief, after animals were anesthe-
tized with a mixture of ketamine (80 mg/kg) and xylazine (12 mg/kg)
intraperitoneally, the abdomen was opened, a stainless wire (outer
diameter, 0.34 mm) was placed on the site of aorta between the right
and left renal artery [23], and then tied around the aorta and the wire,
and then wire was slid out from under the knot, leaving the aorta con-
stricted to the external diameter of the stainless wire. The sham-oper-
ated controls underwent the same procedures without actual ligation
of the aorta. The abdominal wall and the skin were closed with silk su-
ture. The animals were housed in a climate-controlled, light-regulated
space with 12-h light and dark cycles. Two groups were used 7 days
after surgery.
2.3. Measurement of blood pressure and heart rate
Blood pressure was determined 1 week after the aortic coarctation.
Rats were anesthetized with an intraperitoneal injection of the mixture
of ketamine (80 mg/kg) and xylazine (12 mg/kg). Polyethylene tubing
(PE-50) was inserted into the left common carotid artery and femoral
artery, and it was connected with the pressure transducer (Gould
P23XL) that was coupled to a preampliﬁer (Grass Model PI-1,
USA). The systolic, diastolic, mean blood pressure and the heart rate
were analyzed with Chartpro software (Adinstruments, USA).
2.4. Measurement of endothelium-dependent relaxation
The aortas were cut into rings of 2–3 mm in length. Each ring was
connected to an isometric force transducer (MultiMyograph 610M,
Danish Myo Technology, Denmark), suspended in an organ chamber
ﬁlled with 7.5 ml of Krebs buﬀer solution (NaCl 100 mM, KCl
4.7 mM, CaCl2 1.9 mM, MgSO4 1.2 mM, K2HPO4 1.03 mM, NaH-
CO2 25 mM, pH 7.4), and aerated with 95% O2/5% CO2. The isometric
tension was recorded continuously. After a 1 h equilibration period,
the rings were precontracted with phenylephrine (0.3 lM), and then
the endothelium-dependent relaxations were observed with a cumula-
tive addition of acetylcholine (Ach) (1 nM to 10 lM). The relaxations
were expressed as a percentage of the precontracted tension obtained
with phenylephrine (0.3 lM).
2.5. Detection of superoxide anion by lucigenin chemiluminescence
The details of this assay have been published previously [24]. Dark-
adapted lucigenin solution (5 lM) was prepared in aerated Krebs–
Hepes buﬀer. The aortic rings were immersed in the lucigenin solution,
and the chemiluminescence was detected with a Monolight lumino-
meter. The chemiluminescence signal was integrated over 2 min.
2.6. Western blotting
Forty micrograms of protein was separated on 7.5–10% SDS/PAGE
and transferred onto nitrocellulose membranes. After blocking for 1 h
in 5% skim milk solution, the membranes were incubated with speciﬁc
antibodies to manganese superoxide dismutase (Mn SOD) (SOD-110,
Stressgen, USA), copper/zinc superoxide dismutase (Cu/Zn SOD)
(SOD-100, Stressgen, USA), eNOS (SC-654, Santa Cruz, USA), phos-
pho-ser1177-eNOS (#9571, Cell Signaling, USA), phospho-ser36-
p66shc (CN566807, Calbiochem, USA), Shc (SC-1695, Santa Cruz,
USA), and b-actin (SC-1616, Santa Cruz, USA).
Protein expression was detected using an enhanced chemilumines-
cence kit (Amersham Pharmacia Biotech). Western blots were quanti-
ﬁed densitometrically using an ImageQuant software (Molecular
Dynamics).
2.7. Statistical analysis
All data are expressed as the means ± S.E.M. A statistical evaluation
was performed using one-way ANOVA, followed by a Turkey post hoc
test. P < 0.05 was considered statistically signiﬁcant.percentage of the precontracted tension obtained by phenylephrine.
Each value is means ± S.E.M. (n = 6). Note: Endothelium-dependent
relaxation induced by acetylcholine was impaired in the aortic
segments above aortic coarctation compared with sham controls.
SA: The aortic segments above coarctation in sham-operated rats; SB:
the aortic segments below coarctation in sham-operated rats; CA: the
aortic segments above coarctation in coarctation rats; CB: the aortic
segments below coarctation in coarctation rats. aP < 0.05 vs. SA.3. Results
3.1. Change of blood pressure and heart rate
The carotid arterial blood pressures of the abdominal aortic
coarctation rats were signiﬁcantly greater than those of sham-operated rats. In contrast, the femoral arterial blood pressures
were signiﬁcantly lesser than those of sham-operated rats. The
heart rate was not signiﬁcantly diﬀerent between the coarcta-
tion rats and the sham-operated rats (Table 1).
3.2. Endothelial function in aortic coarctation
Endothelium-dependent relaxations to acetylcholine were
signiﬁcantly impaired in the aortic segments above aortic
coarctation compared with the sham controls (35.0 ± 7.1% at
1 lM Ach for CA vs. 86.6 ± 6.0% at 1 lM Ach for SA) (Fig.
1). In contrast, the endothelium-dependent relaxations to ace-
tylcholine remained normal in the aortic segments below aortic
coarctation compared with the sham controls.
3.3. Expression of eNOS and p66shc
The phosphorylation of eNOS and the total eNOS expres-
sion were signiﬁcantly reduced in the aortic segments above
aortic coarctation compared with the sham controls
(22.0 ± 5.7% for p-eNOS and 28.7 ± 8.7% for eNOS, respec-
tively). In contrast, the phosphorylation of eNOS was
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compared with the sham control (P < 0.05, 88.9 ± 12.6% for
CB vs. 120.1 ± 21.8% for SB), even though the total eNOS
expression was not changed (P = ns, 92.3 ± 5.5% for CB vs.
96.8 ± 5.7%) (Fig. 2A).
As shown in Fig. 2B, the p66shc expressions were not chan-
ged by the coarctation. However, the phosphorylation of
p66shc at S36 was signiﬁcantly up-regulated in the aortic seg-
ments above aortic coarctation (252% vs. SA), and it was
down-regulated in the aortic segments below aortic coarctation
compared with the sham controls (72% vs. SB). In the sham-
operated rats, the basal phosphorylation of p66shc in the aor-
tic segments below aortic coarctation was up-regulated com-
pared with that above aortic coarctation (459% vs. SA).
3.4. Vascular superoxide production and the expression of
superoxide dismutase
Compared with the sham controls, the aortic coarctation
group showed a signiﬁcant elevation in basal superoxide pro-
duction both in the aortic segment above and below the aortic
coarctation (506 RLU/mg of aorta for CA, 370 RLU/mg of
aorta for CB) (Fig. 3A). The expressions of Mn SOD and
Cu/Zn SOD were higher in the sham abdominal aorta com-
pared to the sham thoracic aorta (SB: 354% for Mn SOD,
323% for Cu/Zn SOD). Both Mn SOD and Cu/Zn SOD pro-
tein expressions were up-regulated in the aortic segment above
aortic coarctation (CA: 192% for Mn SOD, 423% for Cu/Zn
SOD) (Fig. 3B).
3.5. Eﬀect of angiotensin II on the eNOS and p66shc expression
in MS-1
Abdominal aortic coarctation induces the hypertension via
the activation of renin–angiotensin system [14,15]. Therefore,A Sham        Coarct
eNOS
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Fig. 2. Endothelial nitric oxide synthase (eNOS) and p66shc protein expres
rats. (A) eNOS expression and phosphorylation of eNOS (p-eNOS) at serine
Left bottom shows the summarized plot of eNOS. Expression levels are repre
vs. SA, and bP < 0.05 vs. SB. (B) p66shc and phosphorylation of p66shc (p-p6
Section 2. Right bottom shows the summarized plot of p66shc. Expression lev
aP < 0.05 vs. SA, bP < 0.05 vs. SB, and cP < 0.05 vs. SA. SA: The aortic segm
below coarctation in sham-operated rats; CA: the aortic segments above coarc
coarctation rats.to evaluate the possible role of angiotensin II in the abdominal
aortic coarctation, the eﬀect of angiotensin II on the phosphor-
ylation of p66shc and eNOS was investigated in the MS-1. We
investigated the eﬀect of angiotensin II on the eNOS and
p66shc expression in the cultured MS-1. The treatment of
angiotensin II (0.1 lM) did not change the expression of eNOS
and p66shc in MS-1 for 2 h. However, the treatment of angio-
tensin II signiﬁcantly decreased the phosphorylation of eNOS
in 1 h, in contrast to the increased phosphorylation of p66shc
in 1 h (Fig. 4).4. Discussion
In this study, we demonstrated using the abdominal aortic
coarctation rat model that the phosphorylation of p66shc acts
as an important signal which aﬀects the endothelial dysfunc-
tion. We used the abdominal aortic coarctation rat model
which has shown hypertension in the proximal part and hypo-
tension in the distal part of aortic coarctation within 7 days.
The reduced renal perfusion lasts for 2–6 days after coarcta-
tion [25], therefore, circulating humoral factors are identical
on both sides of the coarctation, the possible causes of the
endothelial dysfunction could be due to the change of barome-
chanical forces or local eﬀects as opposed to systemic humoral
eﬀects in the abdominal aortic coarctation models.
The endothelial dysfunction, reﬂected by impaired endothe-
lium-dependent relaxation, has been reported to occur in the
hypertensive animal model such as aortic coarctation [26,27].
In the present study, aortas above the aortic coarctation that
had been exposed to elevated blood pressure showed an im-
paired endothelium-dependent relaxation. In contrast, the
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Fig. 3. Superoxide production and superoxide dismutases expression in the aortas of abdominal aortic coarctation rats. (A) Superoxide production
was measured with lucigenin chemiluminescence. Each data shows means ± S.E.M. (n = 6). aP < 0.05 vs. SA, and bP < 0.05 vs. SB. (B) Expression of
manganese superoxide dismutase (Mn SOD) and copper/zinc superoxide dismutase (Cu/Zn SOD). Expressions of SODs were measured with Western
blotting. Each data is represented as % of SA. Each bar shows means ± S.E. (n = 6). aP < 0.05 vs. SA, and bP < 0.05 vs. SA. SA: The aortic segments
above coarctation in sham-operated rats; SB: the aortic segments below coarctation in sham-operated rats; CA: the aortic segments above
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Fig. 4. Eﬀect of angiotensin II on eNOS and p66shc expression in the endothelial cell line, MS-1. Cells were harvested after the treatment of
angiotensin II (0.1 lM) for indicated time. Expressions of eNOS and Shc proteins are measured with Western blotting. Upper panels show the typical
data. Each data is represented as % control. Each bar shows means ± S.E.M. (n = 4). aP < 0.05 vs. control.
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gests that high blood pressure may be an important mediator
to impaired endothelium-dependent relaxation in the abdomi-
nal aortic coarctation model.
The impaired endothelium-dependent relaxation in the aor-
tas that had been exposed to elevated blood pressure coincided
with the decreased phosphorylation of eNOS at serine 1197
and the decreased eNOS protein expression. This data suggests
that the decreased phosphorylation of eNOS and/or eNOS
expression is one of the main causes of the impaired endothe-
lium-dependent relaxation. This ﬁnding is consistent with a
previous report that has shown that eNOS mRNA was de-creased in the aortic coarctation model [26]. However, the
underlying mechanism is unclear. The previously reported evi-
dence implies that the decreased expression of eNOS may be
attributed to the altered mechanical force caused by aortic
coarctation such as asynchronous shear stress and circumfer-
ential strain [28].
The intracellular ROS is thought to contribute to the impair-
ment of endothelium-dependent relaxation as the ROS avidly
reacts with NO and inactivates NO in the endothelial cells.
The pivotal role of p66shc in increasing the intracellular
ROS levels is well established [7,9,10]. Especially, the genetic
deletion of p66shc prevents the hyperglycemia-induced or
S.K. Lee et al. / FEBS Letters 582 (2008) 2561–2566 2565age-related endothelial dysfunction and oxidative stress
[11,29].
An important question in this study is how the changes in
blood pressure aﬀect the impaired endothelium-dependent
relaxation of the vascular wall. However, the eﬀect of blood
pressure on the activation of p66shc is not clear. In the present
study, the phosphorylation of p66shc at serine 36 was in-
creased in the aorta that had been exposed to elevated blood
pressure. This data suggests the phosphorylation signal of
p66shc is an important intracellular messenger to the cells ex-
posed to high blood pressure. Therefore, the pharmacological
modulation of p66shc expression or activity could be a novel
and eﬀective target for the treatment of coarctation-induced
hypertension.
The phosphorylation of p66shc in the aorta below coarcta-
tion was greater than that in the aorta above coarctation in
the sham-operated rats as shown in Fig. 2B. The diﬀerence be-
tween the two aortic segments may be related to the mechan-
ical and structural characteristics such as vessel diameters
and diﬀerent physiological changes such as hemodynamics
[30]. Moreover, the increased antioxidant enzyme expression
such as Mn SOD and Cu/Zn SOD (Fig. 3B) in the abdominal
aorta also suggests some relationship with increased phosphor-
ylation of p66shc.
It is interesting that the vascular antioxidant systems such as
the Mn SOD and Cu/Zn SOD expression have been reported
to be up-regulate in the abdominal aorta of the sham-operated
rats [17]. In the present study, SODs also upregulated in the
abdominal aorta more than in the thoracic aorta. Even though
the reason for this could not be discerned, we can suggest that
increased phosphorylation of p66shc would contribute to the
increased vascular antioxidant system. However, the superox-
ide production did not change in the abdominal aorta of sham-
operated rats (Fig. 3A), suggesting the oxidant/antioxidant
system is balanced in the sham-operated rats.
Coincidently with the elevated phosphorylation of p66shc,
the basal superoxide production was increased in the aorta
above the aortic coarctation. The increased superoxide pro-
duction might have aﬀected the impairment of endothelium-
dependent relaxation via inactivation of NO. Mn SOD and
Cu/Zn SOD are up-regulated in the aorta above the aortic
coarctation. This data suggests that the up-regulated SODs
may be acting as a compensatory defense mechanism against
the oxidative stress or oxidative injury. The preserved endothe-
lium-dependent relaxation in the aorta below the aortic coarc-
tation may be attributed to the highly expressed SOD system
in the abdominal aorta of rats.
The inverse correlation found in this study to exist between
the phosphorylation of eNOS and the phosphorylation of
p66shc is consistent with the previously reported gene silencing
of p66shc that promotes the phosphorylation of eNOS at ser-
ine 1197 via the activation of H-ras-dependent Akt activation
in the human endothelial cells [12]. The abdominal aortic
coarctation induces hypertension as the activation of renin–
angiotensin system [14,15,25]. High arterial blood pressure
can also induce the activation of the local renin–angiotensin
system in the vascular wall, contributing to hypertension-in-
duced oxidative stress [19]. Angiotensin II was increased in
the high pressure-exposed cultured arteries [31]. In the present
study, angiotensin II increased the phosphorylation of p66shc
at serine 36, coinciding with the decreased phosphorylation of
eNOS in MS-1. These ﬁndings suggest that the phosphoryla-tion signal of p66shc at serine 36 at the response to angiotensin
II may involve in the superoxide production and the endothe-
lial dysfunction of the abdominal coarctation.
On the basis of the present ﬁndings, it suggests that the in-
creased phosphorylation of p66shc is one of the important
mediators in the impaired endothelium-dependent relaxation
in the aorta exposed to high blood pressure.
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